Implementation of artificial intelligence approaches in oncology clinical trials: A systematic review.

Journal: Artificial intelligence in medicine
PMID: 39837136

Abstract

INTRODUCTION: There is a growing interest in leveraging artificial intelligence (AI) technologies to enhance various aspects of clinical trials. The goal of this systematic review is to assess the impact of implementing AI approaches on different aspects of oncology clinical trials.

Authors

  • Marwa Saady
    Department of Chemistry, School of Sciences & Engineering, The American University in Cairo, AUC Avenue, P. O. Box 74, New Cairo 11835, Egypt.
  • Mahmoud Eissa
    Department of Ophthalmology, Salisbury District Hospital, Odstock Rd, Salisbury SP2 8BJ. United Kingdom.
  • Ahmed S Yacoub
    Bone Muscle Research Center, College of Nursing and Health Innovations, University of Texas, Arlington, TX, United States.
  • Ahmed B Hamed
    Department of Pharmacology, Toxicology, and Biochemistry, Faculty of Pharmacy, Future University in Egypt, Cairo 11835, Egypt.
  • Hassan Mohamed El-Said Azzazy
    Department of Chemistry, School of Sciences & Engineering, The American University in Cairo AUC Avenue, SSE # 1184, P.O. Box 74 New Cairo 11835 Egypt Obaydah.alabrahim@aucegypt.edu hazzazy@aucegypt.edu +20 02 2615 2559.

Keywords

External Resources

Popular Topics
Recent Journals